PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Various terpenoids and dinorditerpenes (e.g., compounds 1, 3, 11, 12) exhibited significant anti-HCV activity in vitro [PMID:30605781, PMID:24400834, PMID:27112277].
Hydro-ethanolic extracts and bergenin showed potential antimalarial activity against Plasmodium falciparum and P. berghei in vitro and in mice [PMID:28273638].
Certain alkaloids (e.g., flueggine B) showed growth inhibitory activity against human breast cancer cell lines (MCF-7 and MDA-MB-231) [PMID:21728296].
Methanolic root bark extract and bergenin significantly reduced the onset and prolonged the duration of sleep in mice [PMID:20161930, PMID:26693416].
Aqueous and ethanolic extracts of the aerial part showed anti-sickle cell activity in vitro using the Emmel technique [PMID:37895986].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 30605781 (2019) — Flueggenoids A - E, new dinorditerpenoids from Flueggea virosa. · Fitoterapia
- 2.PMID: 30721084 (2020) — Fluevirines E and F, two new alkaloids from Flueggea virosa. · Natural product research
- 3.PMID: 38371022 (2024) — The Potential of Cochlospermum tinctorium, Flueggea virosa, and Waltheria indica Traditional Plants From Burkina Faso in Treating Periodontitis: A Systematic Review. · Cureus
- 4.PMID: 39138223 (2024) — Chromosome-level genome assembly and annotation of Flueggea virosa (Phyllanthaceae). · Scientific data
- 5.PMID: 32451096 (2020) — Alkaloid constituents from the fruits of Flueggea virosa.